Clinical Trial Update: Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

View source ↗

Summary

This ClinicalTrials.gov study is evaluating the use of dual-energy spectral CT to evaluate response to first-line therapies in patients with metastatic clear ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Renal Cancer | Status: RECRUITING